Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants

J Affect Disor
15 January 2017
https://www.ncbi.nlm.nih.gov/pubmed/27736689

Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database

Pharmacoepidemiol Drug Saf
June 2017
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485080/

Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use

Am J Emerg Med
August 2017
https://pubmed.ncbi.nlm.nih.gov/28410920/

In patients with fibromyalgia, is low-dose naltrexone effective in alleviating pain, and does it decrease use of oral opioids?

Evidence-Based Practice
June 2017
https://journals.lww.com/ebp/Abstract/2017/06000/In_patients_with_fibromyalgia,_is_low_dose.13.aspx

Alteration of prescription-only drug utilization by low dose naltrexone users with hypothyroidism. A cohort study based on the Norwegian prescription database from 2011-2015

Research in Social and Administrative Pharmacy
May–June 2017
https://www.sciencedirect.com/science/article/abs/pii/S1551741117302152

Chapter 8 Endogenous Opioids in the Etiology and Treatment of Multiple Sclerosis

In Multiple Sclerosis: Perspectives in Treatment and Pathogenesis [Internet]
27 November 2017
https://www.ncbi.nlm.nih.gov/books/NBK470156/

Low-Dose Naltrexone in the Treatment of Fibromyalgia: A Retrospective Analysis

Curr Rheumatol Rev
2018
https://pubmed.ncbi.nlm.nih.gov/28325149/

Background: Fibromyalgia is a chronic pain disorder characterized by diffuse musculoskeletal pain, fatigue, sleep disturbance and cognitive impairment.

Serum [Met 5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone

Exp Biol Med (Maywood)
September 2017
https://pubmed.ncbi.nlm.nih.gov/28766982/

Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients

Front. Immunol
31 October 2019
https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/full

Tolerance to the anticonvulsant effect of morphine in mice: blockage by ultra-low dose naltrexone

Epilepsy Res
February 2009
https://pubmed.ncbi.nlm.nih.gov/19059761/